These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8094432)

  • 1. Immunocytochemical localization of c-erbB-2 protein in transitional cell carcinoma of the urinary bladder.
    Coombs LM; Oliver S; Sweeney E; Knowles M
    J Pathol; 1993 Jan; 169(1):35-42. PubMed ID: 8094432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
    Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
    Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized, high-grade transitional cell carcinoma of the bladder.
    Swanson PE; Frierson HF; Wick MR
    Mod Pathol; 1992 Sep; 5(5):531-6. PubMed ID: 1364264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2 gene product-like expression in urothelial carcinomas of the human bladder. Its value as a prognostic indicator in superficial tumors.
    Serio G
    Pathologica; 1991; 83(1086):413-20. PubMed ID: 1686491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
    Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
    Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique.
    Langner C; Gross C; Rehak P; Ratschek M; Rüschoff J; Zigeuner R
    Urology; 2005 Jan; 65(1):176-80. PubMed ID: 15667899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.
    Rajkumar T; Stamp GW; Pandha HS; Waxman J; Gullick WJ
    J Pathol; 1996 Aug; 179(4):381-5. PubMed ID: 8869284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
    Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
    Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of amplification of c-erb-B2 in bladder carcinoma.
    Lönn U; Lönn S; Friberg S; Nilsson B; Silfverswärd C; Stenkvist B
    Clin Cancer Res; 1995 Oct; 1(10):1189-94. PubMed ID: 9815911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
    Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
    Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
    Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
    J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-erbB2 oncogene product in different tumours and its standardised evaluation.
    Tannapfel A; Kühn R; Kessler H; Wittekind C
    Anal Cell Pathol; 1996 Mar; 10(2):149-60. PubMed ID: 8721956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
    Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
    Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.
    Ohta JI; Miyoshi Y; Uemura H; Fujinami K; Mikata K; Hosaka M; Tokita Y; Kubota Y
    Clin Cancer Res; 2001 Aug; 7(8):2463-7. PubMed ID: 11489827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
    Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
    J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.